Expression and Pharmacology of Endogenous Cav Channels in SH-SY5Y Human Neuroblastoma Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Sousa, Silmara R ^a   Vetter, Irina ^a   Ragnarsson, Lotten ^a   Lewis, Richard J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MESSENGER RNA; MIBEFRADIL; NIFEDIPINE; OMEGA CONOTOXIN CVID; OMEGA CONOTOXIN GVIA; OMEGA CONOTOXIN MVIIA; PIMOZIDE; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM SIGNALING; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE SEQUENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; MALE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VOLTAGE GATED CALCIUM CHANNEL GENE; VOLYAGE GATED CALCIUM CHANNEL 1.3 GENE; VOLYAGE GATED CALCIUM CHANNEL 2.2 GENE; VOLYAGE GATED CALCIUM CHANNEL 3.1 GENE; VOLYAGE GATED CALCIUM CHANNEL SUBUNIT ALPHA2 DELTA1-3 GENE; VOLYAGE GATED CALCIUM CHANNEL SUBUNIT BETA1 GENE; VOLYAGE GATED CALCIUM CHANNEL SUBUNIT BETA3 GENE; VOLYAGE GATED CALCIUM CHANNEL SUBUNIT BETA4 GENE; VOLYAGE GATED CALCIUM CHANNEL SUBUNIT GAMMA1 GENE; VOLYAGE GATED CALCIUM CHANNEL SUBUNIT GAMMA4-5 GENE; VOLYAGE GATED CALCIUM CHANNEL SUBUNIT GAMMA7 GENE;

BINDING, COMPETITIVE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL LINE, TUMOR; CELL MEMBRANE; GENE EXPRESSION; HUMANS; NEUROBLASTOMA; OMEGA-CONOTOXIN GVIA; PROTEIN BINDING; PROTEIN ISOFORMS;

RATTUS;

EID: 84875450614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059293     Document Type: Article

References (64)

1. Hynd MR, Scott HL, Dodd PR, (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochemistry International 45: 583-595.
2. Alicino I, Giglio M, Manca F, Bruno F, Puntillo F, (2012) Intrathecal combination of ziconotide and morphine for refractory cancer pain: A rapidly acting and effective choice. Pain 153: 245-249.
3. Catterall WA, (2000) Structure and regulation of voltage-gated Ca2+ channels. Annual review of cell and developmental biology 16: 521-555.
4. Feng ZP, Hamid J, Doering C, Bosey GM, Snutch TP, et al. (2001) Residue Gly1326 of the N-type calcium channel alpha 1B subunit controls reversibility of omega-conotoxin GVIA and MVIIA block. J Biol Chem 276: 15728-15735.
5. Catterall WA, Cestele S, Yarov-Yarovoy V, Yu FH, Konoki K, et al. (2007) Voltage-gated ion channels and gating modifier toxins. Toxicon 49: 124-141.
6. Yu FH, Catterall WA, (2004) The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis. Sci STKE 2004: re15.
7. Lewis RJ, Dutertre S, Vetter I, Christie MJ, (2012) Conus venom peptide pharmacology. Pharmacol Rev 64: 259-298.
8. Catterall WA, Goldin AL, Waxman SG, (2003) International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: sodium channels. Pharmacological reviews 55: 575-578.
9. Catterall WA (2011) Voltage-gated calcium channels. Cold Spring Harbor Perspectives in Biology 3.
10. Olivera BM, Miljanich GP, Ramachandran J, Adams ME, (1994) Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins. Annu Rev Biochem 63: 823-867.
11. Dolphin AC, (2009) Calcium channel diversity: multiple roles of calcium channel subunits. Curr Opin Neurobiol 19: 237-244.
12. Arikkath J, Campbell KP, (2003) Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol 13: 298-307.
13. Reeve HL, Vaughan PFT, Peers C, (1994) Calcium Channel Currents in Undifferentiated Human Neuroblastoma (SH-SY5Y) Cells: Actions and Possible Interactions of Dihydropyridines and ω-Conotoxin. European Journal of Neuroscience 6: 943-952.
14. Reuveny E, Narahashi T, (1993) Two types of high voltage-activated calcium channels in SH-SY5Y human neuroblastoma cells. Brain Res 603: 64-73.
15. Vaughan PFT, Peers C, Walker JH, (1995) The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline release. General Pharmacology: The Vascular System 26: 1191-1201.
16. Kaneko S, Cooper CB, Nishioka N, Yamasaki H, Suzuki A, et al. (2002) Identification and characterization of novel human Cav2.2 (alpha 1B) calcium channel variants lacking the synaptic protein interaction site. J Neurosci 22: 82-92.
17. Williams ME, Brust PF, Feldman DH, Patthi S, Simerson S, et al. (1992) Structure and functional expression of an omega-conotoxin-sensitive human N-type calcium channel. Science 257: 389-395.
18. Szabo Z, Obermair GJ, Cooper CB, Zamponi GW, Flucher BE, (2006) Role of the synprint site in presynaptic targeting of the calcium channel Cav2.2 in hippocampal neurons. European Journal of Neuroscience 24: 709-718.
19. Chiou W-F, (2006) Effect of Aβ exposure on the mRNA expression patterns of voltage-sensitive calcium channel α1 subunits (α1A-α1D) in human SK-N-SH neuroblastoma. Neurochem Int 49: 256-261.
20. Schroeder CI, Lewis RJ, (2006) ω-conotoxins GVIA, MVIIA and CVID: SAR and clinical potential. Marine Drugs 4: 193-214.
21. Lewis RJ, Nielsen KJ, Craik DJ, Loughnan ML, Adams DA, et al. (2000) Novel ω-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. Journal of Biological Chemistry 275: 35335-35344.
22. Mould J, Yasuda T, Schroeder CI, Beedle AM, Doering CJ, et al. (2004) The alpha2delta auxiliary subunit reduces affinity of omega-conotoxins for recombinant N-type (Cav2.2) calcium channels. J Biol Chem 279: 34705-34714.
23. Berecki G, Motin L, Haythornthwaite A, Vink S, Bansal P, et al. (2010) Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels. Mol Pharmacol 77: 139-148.
24. Benjamin ER, Pruthi F, Olanrewaju S, Shan S, Hanway D, et al. (2006) Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR. Biochem Pharmacol 72: 770-782.
25. Dai G, Haedo RJ, Warren VA, Ratliff KS, Bugianesi RM, et al. (2008) A high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors. Assay Drug Dev Technol 6: 195-212.
26. Finley MF, Lubin ML, Neeper MP, Beck E, Liu Y, et al. (2010) An integrated multiassay approach to the discovery of small-molecule N-type voltage-gated calcium channel antagonists. Assay Drug Dev Technol 8: 685-694.
27. Furukawa T, Yamakawa T, Midera T, Sagawa T, Mori Y, et al. (1999) Selectivities of dihydropyridine derivatives in blocking Ca2+ channel subtypes expressed in Xenopus oocytes. J Pharmacol Exp Ther 291: 464-473.
28. Nowycky MC, Fox AP, Tsien RW, (1985) Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316: 440-443.
29. Trombley P, Westbrook G, (1991) Voltage-gated currents in identified rat olfactory receptor neurons. The Journal of Neuroscience 11: 435-444.
30. Motin L, Yasuda T, Schroeder CI, Lewis RJ, Adams DJ, (2007) w-Conotoxin inhibition of excitatory synaptic transmission evoked by dorsal root stimulation in rat superficial dorsal horn-conotoxin CVIB differentially inhibits native and recombinant N- and P/Q-type calcium channels. Eur J Neurosci 25: 435-444.
31. Alvarez Maubecin V, Sanchez VN, Rosato Siri MD, Cherksey BD, Sugimori M, et al. (1995) Pharmacological characterization of the voltage-dependent Ca2+ channels present in synaptosomes from rat and chicken central nervous system. J Neurochem 64: 2544-2551.
32. Martin RL, Lee JH, Cribbs LL, Perez-Reyes E, Hanck DA, (2000) Mibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther 295: 302-308.
33. Viana F, Van Den Bosch L, Missiaen L, Vandenberghe W, Droogmans G, et al. (1997) Mibefradil (Ro 40m5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones. Cell Calcium 22: 299-311.
34. Arnoult C, Villaz M, Florman HM, (1998) Pharmacological properties of the T-type Ca2+ current of mouse spermatogenic cells. Mol Pharmacol 53: 1104-1111.
35. Todorovic SM, Lingle CJ, (1998) Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents. J Neurophysiol 79: 240-252.
36. Cizkova D, Marsala J, Lukacova N, Marsala M, Jergova S, et al. (2002) Localization of N-type Ca2+ channels in the rat spinal cord following chronic constrictive nerve injury. Exp Brain Res 147: 456-463.
37. Wallace MS, Rauck RL, Deer T, (2010) Ziconotide combination intrathecal therapy: rationale and evidence. Clin J Pain 26: 635-644.
38. Lambert DG, Whitham EM, Baird JG, Nahorski SR, (1990) Different mechanisms of Ca2+ entry induced by depolarization and muscarinic receptor stimulation in SH-SY5Y human neuroblastoma cells. Molecular Brain Research 8: 263-266.
39. Williams ME, Feldman DH, McCue AF, Brenner R, (1992) Structure and functional expression of alpha 1, alpha 2, and beta subunits of a novel human neuronal calcium channel subtype. Neuron (Cambridge, Mass) 8: 71-84.
40. Xie X, Van Deusen AL, Vitko I, Babu DA, Davies LA, et al. (2007) Validation of high throughput screening assays against three subtypes of Ca(v)3 T-type channels using molecular and pharmacologic approaches. Assay Drug Dev Technol 5: 191-203.
41. Bezprozvanny I, Tsien RW, (1995) Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967). Mol Pharmacol 48: 540-549.
42. Bell TJ, Thaler C, Castiglioni AJ, Helton TD, Lipscombe D, (2004) Cell-Specific Alternative Splicing Increases Calcium Channel Current Density in the Pain Pathway. Neuron 41: 127-138.
43. Sonnier H, Kolomytkin OV, Marino AA, (2000) Resting potential of excitable neuroblastoma cells in weak magnetic fields. Cell Mol Life Sci 57: 514-520.
44. Nielsen KJ, Schroeder T, Lewis R, (2000) Structure-activity relationships of omega-conotoxins at N-type voltage-sensitive calcium channels. J Mol Recognit 13: 55-70.
45. Lipscombe D, Pan JQ, Gray AC, (2002) Functional diversity in neuronal voltage-gated calcium channels by alternative splicing of Ca(v)alpha1. Mol Neurobiol 26: 21-44.
46. Lipscombe D, Raingo J, (2007) Alternative splicing matters: N-type calcium channels in nociceptors. Channels (Austin) 1: 225-227.
47. Lin Z, Haus S, Edgerton J, Lipscombe D, (1997) Identification of functionally distinct isoforms of the N-type Ca2+ channel in rat sympathetic ganglia and brain. Neuron 18: 153-166.
48. Brust PF, Simerson S, McCue AF, Deal CR, Schoonmaker S, et al. (1993) Human neuronal voltage-dependent calcium channels: studies on subunit structure and role in channel assembly. Neuropharmacology 32: 1089-1102.
49. Zamponi GW, McCleskey EW, (2004) Splicing it up: a variant of the N-type calcium channel specific for pain. Neuron 41: 3-4.
50. Maximov A, Bezprozvanny I, (2002) Synaptic targeting of N-type calcium channels in hippocampal neurons. J Neurosci 22: 6939-6952.
51. Jimenez C, Bourinet E, Leuranguer V, Richard S, Snutch TP, et al. (2000) Determinants of voltage-dependent inactivation affect Mibefradil block of calcium channels. Neuropharmacology 39: 1-10.
52. Sandoval A, Arikkath J, Monjaraz E, Campbell KP, Felix R, (2007) Gamma1-dependent down-regulation of recombinant voltage-gated Ca2+ channels. Cellular and molecular neurobiology 27: 901-908.
53. Moss FJ, Viard P, Davies A, Bertaso F, Page KM, et al. (2002) The novel product of a five-exon stargazin-related gene abolishes Cav2.2 calcium channel expression. EMBO J 21: 1514-1523.
54. Ferron L, Davies A, Page KM, Cox DJ, Leroy J, et al. (2008) The stargazin-related protein gamma 7 interacts with the mRNA-binding protein heterogeneous nuclear ribonucleoprotein A2 and regulates the stability of specific mRNAs, including Cav2.2. J Neurosci 28: 10604-10617.
55. Kang MG, Chen CC, Felix R, Letts VA, Frankel WN, et al. (2001) Biochemical and biophysical evidence for gamma 2 subunit association with neuronal voltage-activated Ca2+ channels. J Biol Chem 276: 32917-32924.
56. Sharp AH, Black JL, 3rd, Dubel SJ, Sundarraj S, Shen JP, et al (2001) Biochemical and anatomical evidence for specialized voltage-dependent calcium channel gamma isoform expression in the epileptic and ataxic mouse, stargazer. Neuroscience 105: 599-617.
57. Lacinova L, (2005) Voltage-dependent calcium channels. Gen Physiol Biophys 24Suppl 1: 1-78.
58. Dold KM, Greenlee WF, (1990) Filtration assay for quantitation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) specific binding to whole cells in culture. Anal Biochem 184: 67-73.
59. Vetter I, Mozar CA, Durek T, Wingerd JS, Alewood PF, et al. (2012) Characterisation of Nav types endogenously expressed in human SH-SY5Y neuroblastoma cells. Biochemical Pharmacology 83: 1562-1571.
60. Maximov A, Bezprozvanny I, (2002) Synaptic Targeting of N-Type Calcium Channels in Hippocampal Neurons. The Journal of Neuroscience 22: 6939-6952.
61. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) "Basic local alignment search tool" J. Mol. Biol. 403-410.
62. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, et al. (2012) Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13: 134.
63. Wagner J, Snowman A, Biswas A, Olivera B, Snyder S, (1988) ω- conotoxin GVIA binding to a high affinity receptor in brain: Characterization, calcium sensitivity and Solubilization. The Journal of Neuroscience 9: 3354-3359.
64. Ahmad S, Miljanich G, (1988) The calcium channel antagonist, omega-conotoxin, and electric organ nerve terminals: binding and inhibition of transmitter release and calcium influx. 453: 247-256.